Welcome to LookChem.com Sign In|Join Free

CAS

  • or

168210-66-0

Post Buying Request

168210-66-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 3-Pyrrolidinecarboxylic acid, 3-[(diphenylmethylene)amino]-1-(phenylmethyl)-, methyl ester

    Cas No: 168210-66-0

  • No Data

  • No Data

  • No Data

  • Kono Chem Co.,Ltd
  • Contact Supplier

168210-66-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 168210-66-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,8,2,1 and 0 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 168210-66:
(8*1)+(7*6)+(6*8)+(5*2)+(4*1)+(3*0)+(2*6)+(1*6)=130
130 % 10 = 0
So 168210-66-0 is a valid CAS Registry Number.

168210-66-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(benzhydrylidene-amino)-1-benzyl-pyrrolidne-3-carboxylic acid methyl ester

1.2 Other means of identification

Product number -
Other names 3-(Benzhydrylidene-amino)-1-benzyl-pyrrolidine-3-carboxylic acid methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:168210-66-0 SDS

168210-66-0Relevant articles and documents

INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE

-

Page 86, (2010/02/06)

This invention discloses amino acid derivatives which display inhibitory effects on the serine protease factor Xa. The invention also discloses pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable compositions comprising the compounds or their salts, methods for the preparation of the compounds, and methods of using them as therapeutic agents for treating or preventing disease states in mammals characterized by abnormal thrombosis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 168210-66-0